Earnings call transcript: Haemonetics Q3 2024 sees EPS beat, stock drops
Haemonetics Corporation (market cap: $3.23B) reported its third-quarter earnings for fiscal year 2024, surpassing analysts' expectations with an adjusted earnings per share (EPS) of $1.19, slightly ...
Haemonetics Corporation (HAE) Q3 2025 Earnings Call Transcript
Q3 2025 Earnings Conference Call February 6, 2025 8:30 AM ETCompany ParticipantsOlga Guyette - Vice President, ...